Ligand profile
ZINC127654
Virtual-screening candidate from ZINC.
Bound to: KP13_03130 — Dihydropteroate synthase type-1
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC127654- UniProt (similar protein)
Q5SLV2- Tanimoto
- 0.739
- Target protein
- KP13_03130
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 72.5
- −1 ≤ LogP ≤ 5 2.76
- MW ≤ 500 Da 229.2
- LogP ≤ 5 2.76
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 72.5
Matches PAINS filter: anil_no_alk(40). May be a frequent false positive in HTS — review carefully.
Chemical representations
Canonical representations for cheminformatics workflows.
Nc1ccc(Oc2ccc(C(=O)O)cc2)cc1Nc1ccc(Oc2ccc(C(=O)O)cc2)cc1
InChI=1S/C13H11NO3/c14-10-3-7-12(8-4-10)17-11-5-1-9(2-6-11)13(15)16/h1-8H,14H2,(H,15,16)InChI=1S/C13H11NO3/c14-10-3-7-12(8-4-10)17-11-5-1-9(2-6-11)13(15)16/h1-8H,14H2,(H,15,16)
DVFCGSZRLJQHJA-UHFFFAOYSA-NDVFCGSZRLJQHJA-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- PAB
- Homolog
- Q5SLV2
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC127654 →
- ZINC ZINC20 ZINC127654 →
- UniProt UniProt Q5SLV2 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC127654”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_03130.
PDB 47
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 26
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).